UNP-0089 Enterotoxemia (Overeating Disease) in Sheep and Goats
Enterotoxemia (Overeating Disease) in Sheep and Goats
Introduction
Enterotoxemia, also known as overeating or pulpy kidney disease,
is a condition caused by the absorption of a large amount of toxins
from the intestines. Clostridium perfringens types C &
D are bacteria normally found in the soil and as part of the
normal microflora in the gastrointestinal tract of a healthy sheep
and goats. Under certain conditions, these bacteria can rapidly
reproduce in the animals, producing large quantities of toxins.
The toxins cause enterocolitis (inflammation of the intestine),
increase the permeability of the blood vessels, and become absorbed
in the blood. They circulate in the bloodstream, promoting swelling
in the lungs and kidneys, giving the condition the name pulpy
kidney disease.
Young animals are most susceptible. Sudden and high mortality
rates are concentrated in lambs and kids. Although adult animals
are also susceptible to enterotoxemia, they develop immunity due
to frequent exposure to these toxins.
Factors Associated with Enterotoxemia Outbreaks
Sheep and goats are more likely to produce too much Clostridium
perfringens types C & D in the gut, and suffer from enterotoxemia,
during conditions such as the following:
- When kids and lambs excessively consume milk or feed with
high quantities of grain
- While recovering from an illness or distress; when natural
immunity is compromised
- As a consequence of heavy infestations of gastrointestinal
parasites, such as nematodes (worms) and coccidia
- When animals have a diet rich in grains and low in dry matter
(hay or green grass)
- When animals have any condition or disease that slows the
peristalsis (motility of the gastrointestinal tract)
Common Signs of Enterotoxemia
- Most frequent in young animals, the peracute form is characterized
by sudden death that occurs 12 hours after the first signs of
the disease appear. Sudden death occurs only minutes after a
lamb or a kid shows signs of central nervous system alteration.
These signs are excitement and convulsion, followed by death.
- Loss of appetite
- Abdominal discomfort, shown by kicking at the belly and arching
the back
- Profuse diarrhea (watery consistence with or without blood)
- Fever (105 F; 40.5 C)
- The chronic form is most frequent in adults. Off and on for
about a week, the animal may be depressed, have a reduced appetite,
and lose body weight.
Diagnosis, Treatment, and Prevention
Diagnosis
Diagnosis is based on clinical signs, and history of sudden
death that can be confirmed by necropsy. Diagnosis can be confirmed
by positive identification of enterocolitis (inflammation of the
intestine), Clostridium perfringens types C & D from
the feces, and gut content and kidneys cultured and isolated from
the affected animals.
The presence of glucosuria (high levels of sugar in the urine)
can indicate enterotoxemia.
Postmortem data are important for the diagnosis of enterotoxemia.
Therefore, dead animals should be submitted to necropsy and their
tissues sent to a diagnostic laboratory for confirmation of the
clinical diagnosis. A postmortem examination of the large and
small intestines can identify a high collection of watery blood
and fibrinous clots, and numerous ulcers on the mucosa (internal
layer of the intestines). The brain and kidney tissues may show
softening. Specific DNA testing assays can help detect enterotoxemia
in postmortem animals.
Treatment
Recommended treatments include the following:
- Administering C & D Antitoxin according to the manufacturer's
recommendation. Kids are normally treated with 5 mL of C &
D Antitoxin subcutaneously.
- Administering penicillin.
- Orally administering an antacid.
- Administering anti-bloating medication.
- Reducing pain by applying Banamine (as prescribed by a veterinarian).
- Administering thiamin (vitamin B1) I.M intramuscularly.
- Replacing fluids intravenously or subcutaneously, and using
corticosteroids.
- Using probiotics after treatment with antibiotics to encourage
repopulation of the microflora in the rumen and guts.
Prevention
All animals in a herd should be vaccinated against enterotoxemia.
Vaccination will reduce the chances that animals will contract
enterotoxemia.
Vaccination Protocal
- Vaccinate pregnant animals with C/D&T vaccines during
the fourth month of pregnancy. This procedure will enrich the
colostrum (first milky secretion produced between one and three
days after birth) with antibodies (specific proteins) that will
protect the newborn against enterotoxemia.
- All young animals should be vaccinated at four weeks of age
and then 30 days later. Administer another booster dose at the
time of weaning.
- Vaccinate bucks and all adult animals once a year.
NOTE: Use vaccines labeled for sheep
and goats. Some of the vaccines against enterotoxemia are also
associated with the tetanus vaccine. |
Vaccination Procedure
- Do not vaccinate goats within 21 days before slaughter.
- Vaccinate animals that appear healthy; avoid vaccinating
animals sick with fever or worms. These animals may not respond
well to the vaccine because their immune systems may be weakened.
- Keep good records of the herd.
- Use a new needle for each animal.
- Disinfect the injection site with alcohol.
- Avoid causing stress to the animals during vaccination. Handle
the herd in a peaceful manner; avoid accidents and noise when
working with goats.
- In case of anaphylaxis (body reation) caused by a vaccine,
use epinephrine or its equivalent.
- Refer to label instructions for product use and storage before
vaccinating.
NOTE: Some products mentioned are not
approved by the United States Food and Drug Administration for
use in meat or dairy goats. Therefore, their uses are considered
extra-labeled. Consult a local veterinarian before using products
in an extra-labeled manner. |
References
Bath, G. F., van Wyk, J. A., Pettey, K. P. (2005). Control
measures for some important and unusual goat diseases in South
Africa. Small Ruminant Research, (60), 127-140.
Blackwell, T. E., Butler, D. G. (January 15, 1992). Clinical
signs, treatment, and postmortem lesions in dairy goats with enterotoxemia:
13 cases (1979-1982). Journal of the American Veterinary Medical
Association, (2), 214-217.
Fernandez-Miyakawa, M. E., Uzal, F. A. (2003). The early effects
of Clostridium perfringens type D epsilon toxin in ligated intestinal
loops of goats and sheep. Veterinary Research Communications,
(3), 231-241.
Miserez, R., Frey, J., Buogo, C., Capaul, S., Tontis, A., Burnens,
A., et al. (1998). Detection of alpha and epsilon toxigenic Clostridium
perfringens type D in sheep and goats using a DNA amplification
technique (PCR). Letters in Applied Microbiology,
26(5), 382-386.
Pugh, D. G. (2002). Sheep and goat medicine. Philadelphia,
PA: W. B. Saunders Company, 262-263.
Merck & Company, Inc. (2006). Type
D enterotoxemias. The Merck Veterinary Manual. Retrieved
February 14, 2007.
Uzael, F. A., & Kelly, W. R. (1998). Protection of goats
against experimental enterotoxemia by vaccination with Clostridium
perfringens type D epsilon toxoid. The Veterinary Record,
142(26), 722-725.
Uzael, F. A., Plumb, J. J., Blackall, L. L., & Kelly, W.
R. (1997). PCR detection of Clostridium perfringens producing
different toxins in faeces of goats. Letters in Applied Microbiology,
25(5), 339-344.
Uzael, F. A., Pasini, M. I., Olaechea, F. V., Robles, C. A.,
& Elizondo, A. (1994). An outbreak of enterotoxemia caused
by Clostridium perfringens type D in goats in Patagonia. Veterinary
Record, 135(12), 279-280.
Maria Lenira Leite-Browning, DVM, MS, Extension Animal Scientist,
Alabama A&M University
For more information, contact your county Extension office. Visit http://www.aces.edu/counties or look in your telephone directory under your county's name to find contact information.
Issued in furtherance of Cooperative Extension work in agriculture and
home economics, Acts of May 8 and June 30, 1914, and other related
acts, in cooperation with the U.S. Department of Agriculture. The Alabama
Cooperative Extension System (Alabama A&M University and Auburn
University) offers educational programs, materials, and equal
opportunity employment to all people without regard to race, color,
national origin, religion, sex, age, veteran status, or disability.
|
If you have problems loading
this document, please email publications@aces.edu
for assistance.
Publications Homepage | ACES Homepage
|